TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof,are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHI, Jianliang, GUO, Junqing, PATTON, Matthew Reiser, YANG, Michael G, HART, Amy C, XIAO, Zili, WU, Yong-Jin, CHEN, Jie, HU, Xirui, DZIERBA, Carolyn Diane, FRENNESSON, David B, SPERGEL, Steven H, LUO, Guanglin, MERTZMAN, Michael E, VENABLES, Brian Lee
Format: Patent
Sprache:eng ; fin
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHI, Jianliang
GUO, Junqing
PATTON, Matthew Reiser
YANG, Michael G
HART, Amy C
XIAO, Zili
WU, Yong-Jin
CHEN, Jie
HU, Xirui
DZIERBA, Carolyn Diane
FRENNESSON, David B
SPERGEL, Steven H
LUO, Guanglin
MERTZMAN, Michael E
VENABLES, Brian Lee
description Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof,are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI4229056TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI4229056TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI4229056TT33</originalsourceid><addsrcrecordid>eNrjZDAICfJ0jPL38Q-IDPJ08fSL9FFw9vcN8A_1cwlWcAxW8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxbp4mRkaWBqZmISHGxsSoAQB5Uic5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS</title><source>esp@cenet</source><creator>SHI, Jianliang ; GUO, Junqing ; PATTON, Matthew Reiser ; YANG, Michael G ; HART, Amy C ; XIAO, Zili ; WU, Yong-Jin ; CHEN, Jie ; HU, Xirui ; DZIERBA, Carolyn Diane ; FRENNESSON, David B ; SPERGEL, Steven H ; LUO, Guanglin ; MERTZMAN, Michael E ; VENABLES, Brian Lee</creator><creatorcontrib>SHI, Jianliang ; GUO, Junqing ; PATTON, Matthew Reiser ; YANG, Michael G ; HART, Amy C ; XIAO, Zili ; WU, Yong-Jin ; CHEN, Jie ; HU, Xirui ; DZIERBA, Carolyn Diane ; FRENNESSON, David B ; SPERGEL, Steven H ; LUO, Guanglin ; MERTZMAN, Michael E ; VENABLES, Brian Lee</creatorcontrib><description>Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof,are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.</description><language>eng ; fin</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240618&amp;DB=EPODOC&amp;CC=FI&amp;NR=4229056T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240618&amp;DB=EPODOC&amp;CC=FI&amp;NR=4229056T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHI, Jianliang</creatorcontrib><creatorcontrib>GUO, Junqing</creatorcontrib><creatorcontrib>PATTON, Matthew Reiser</creatorcontrib><creatorcontrib>YANG, Michael G</creatorcontrib><creatorcontrib>HART, Amy C</creatorcontrib><creatorcontrib>XIAO, Zili</creatorcontrib><creatorcontrib>WU, Yong-Jin</creatorcontrib><creatorcontrib>CHEN, Jie</creatorcontrib><creatorcontrib>HU, Xirui</creatorcontrib><creatorcontrib>DZIERBA, Carolyn Diane</creatorcontrib><creatorcontrib>FRENNESSON, David B</creatorcontrib><creatorcontrib>SPERGEL, Steven H</creatorcontrib><creatorcontrib>LUO, Guanglin</creatorcontrib><creatorcontrib>MERTZMAN, Michael E</creatorcontrib><creatorcontrib>VENABLES, Brian Lee</creatorcontrib><title>TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS</title><description>Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof,are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAICfJ0jPL38Q-IDPJ08fSL9FFw9vcN8A_1cwlWcAxW8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxbp4mRkaWBqZmISHGxsSoAQB5Uic5</recordid><startdate>20240618</startdate><enddate>20240618</enddate><creator>SHI, Jianliang</creator><creator>GUO, Junqing</creator><creator>PATTON, Matthew Reiser</creator><creator>YANG, Michael G</creator><creator>HART, Amy C</creator><creator>XIAO, Zili</creator><creator>WU, Yong-Jin</creator><creator>CHEN, Jie</creator><creator>HU, Xirui</creator><creator>DZIERBA, Carolyn Diane</creator><creator>FRENNESSON, David B</creator><creator>SPERGEL, Steven H</creator><creator>LUO, Guanglin</creator><creator>MERTZMAN, Michael E</creator><creator>VENABLES, Brian Lee</creator><scope>EVB</scope></search><sort><creationdate>20240618</creationdate><title>TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS</title><author>SHI, Jianliang ; GUO, Junqing ; PATTON, Matthew Reiser ; YANG, Michael G ; HART, Amy C ; XIAO, Zili ; WU, Yong-Jin ; CHEN, Jie ; HU, Xirui ; DZIERBA, Carolyn Diane ; FRENNESSON, David B ; SPERGEL, Steven H ; LUO, Guanglin ; MERTZMAN, Michael E ; VENABLES, Brian Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI4229056TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fin</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHI, Jianliang</creatorcontrib><creatorcontrib>GUO, Junqing</creatorcontrib><creatorcontrib>PATTON, Matthew Reiser</creatorcontrib><creatorcontrib>YANG, Michael G</creatorcontrib><creatorcontrib>HART, Amy C</creatorcontrib><creatorcontrib>XIAO, Zili</creatorcontrib><creatorcontrib>WU, Yong-Jin</creatorcontrib><creatorcontrib>CHEN, Jie</creatorcontrib><creatorcontrib>HU, Xirui</creatorcontrib><creatorcontrib>DZIERBA, Carolyn Diane</creatorcontrib><creatorcontrib>FRENNESSON, David B</creatorcontrib><creatorcontrib>SPERGEL, Steven H</creatorcontrib><creatorcontrib>LUO, Guanglin</creatorcontrib><creatorcontrib>MERTZMAN, Michael E</creatorcontrib><creatorcontrib>VENABLES, Brian Lee</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHI, Jianliang</au><au>GUO, Junqing</au><au>PATTON, Matthew Reiser</au><au>YANG, Michael G</au><au>HART, Amy C</au><au>XIAO, Zili</au><au>WU, Yong-Jin</au><au>CHEN, Jie</au><au>HU, Xirui</au><au>DZIERBA, Carolyn Diane</au><au>FRENNESSON, David B</au><au>SPERGEL, Steven H</au><au>LUO, Guanglin</au><au>MERTZMAN, Michael E</au><au>VENABLES, Brian Lee</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS</title><date>2024-06-18</date><risdate>2024</risdate><abstract>Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof,are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fin
recordid cdi_epo_espacenet_FI4229056TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T16%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHI,%20Jianliang&rft.date=2024-06-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI4229056TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true